Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationCarmen Martı́nez, Anna Sureda, Carmen Canals et al.|Annals of Oncology|2013Cited by 105
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysisAlexander Greb, Andreas Engert, Julia Bohlius et al.|Cancer Treatment Reviews|2007Cited by 86
Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free RemissionMaría Agustina Perusini, Dennis Dong Hwan Kim, Carmen Fava et al.|Blood|2023Cited by 0